| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| MOH - MOH | HOLD | 0 @ USD 322.19 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 322.19. The average price that MOH shares were previous bought at was USD 307.818. The current market price is 4.7% higher than average price they were purchased at. The value of the holding in MOH has fallen by USD 265,836 compared to the previous valuation of MOH |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | HOLD | 0 @ USD 322.19 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 322.19. The average price that MOH shares were previous bought at was USD 307.818. The current market price is 4.7% higher than average price they were purchased at. The value of the holding in MOH has fallen by USD 265,836 compared to the previous valuation of LVMH Moët Hennessy - Louis Vuitton Société Européenne |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 411.49 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 411.49. The average price that IDXX shares were previous bought at was USD 438.202. The current market price is -6.1% lower than average price they were purchased at. The value of the holding in IDXX has increased by USD 350,033 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| HUM - Hummingbird Resources PLC | HOLD | 0 @ USD 264.48 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 264.48. The average price that HUM shares were previous bought at was USD 272.131. The current market price is -2.8% lower than average price they were purchased at. The value of the holding in HUM has fallen by USD 1,195,578 compared to the previous valuation of Hummingbird Resources PLC |
| HUM - Humana Inc | HOLD | 0 @ USD 264.48 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 264.48. The average price that HUM shares were previous bought at was USD 272.131. The current market price is -2.8% lower than average price they were purchased at. The value of the holding in HUM has fallen by USD 1,195,578 compared to the previous valuation of Humana Inc |
| CNC - Concurrent Technologies Plc | HOLD | 0 @ USD 60.7 | USD 0 | The current share valuation price of CNC based on adjusted close was USD 60.7. The average price that CNC shares were previous bought at was USD 60.1823. The current market price is 0.9% higher than average price they were purchased at. The value of the holding in CNC has fallen by USD 302,293 compared to the previous valuation of Concurrent Technologies Plc |
| CAH - Cardinal Health Inc | HOLD | 0 @ USD 134.71 | USD 0 | The current share valuation price of CAH based on adjusted close was USD 134.71. The average price that CAH shares were previous bought at was USD 127.212. The current market price is 5.9% higher than average price they were purchased at. The value of the holding in CAH has increased by USD 40,141 compared to the previous valuation of Cardinal Health Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| DXCM - DexCom Inc | HOLD | 0 @ USD 68.57 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 68.57. The average price that DXCM shares were previous bought at was USD 78.5289. The current market price is -12.7% lower than average price they were purchased at. The value of the holding in DXCM has fallen by USD 29,668 compared to the previous valuation of DexCom Inc |
| MTD - Mettler-Toledo International Inc | HOLD | 0 @ USD 1004.96 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1004.96. The average price that MTD shares were previous bought at was USD 1258.05. The current market price is -20.1% lower than average price they were purchased at. The value of the holding in MTD has fallen by USD 116,000 compared to the previous valuation of Mettler-Toledo International Inc |
| MTD - AMUNDI EUR GOV 710 | HOLD | 0 @ USD 1004.96 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1004.96. The average price that MTD shares were previous bought at was USD 1258.05. The current market price is -20.1% lower than average price they were purchased at. The value of the holding in MTD has fallen by USD 116,000 compared to the previous valuation of AMUNDI EUR GOV 710 |
| BIIB - Biogen Inc | HOLD | 0 @ USD 118.61 | USD 0 | The current share valuation price of BIIB based on adjusted close was USD 118.61. The average price that BIIB shares were previous bought at was USD 147.936. The current market price is -19.8% lower than average price they were purchased at. The value of the holding in BIIB has increased by USD 227,925 compared to the previous valuation of Biogen Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| WST - West Pharmaceutical Services Inc | HOLD | 0 @ USD 201.9 | USD 0 | The current share valuation price of WST based on adjusted close was USD 201.9. The average price that WST shares were previous bought at was USD 264.303. The current market price is -23.6% lower than average price they were purchased at. The value of the holding in WST has fallen by USD 246,832 compared to the previous valuation of West Pharmaceutical Services Inc |
| WAT - Waters Corporation | HOLD | 0 @ USD 321.01 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 321.01. The average price that WAT shares were previous bought at was USD 373.416. The current market price is -14.0% lower than average price they were purchased at. The value of the holding in WAT has fallen by USD 2,501 compared to the previous valuation of Waters Corporation |
| WAT - MULETFWATIMETFP | HOLD | 0 @ USD 321.01 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 321.01. The average price that WAT shares were previous bought at was USD 373.416. The current market price is -14.0% lower than average price they were purchased at. The value of the holding in WAT has fallen by USD 2,501 compared to the previous valuation of MULETFWATIMETFP |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 97.92 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 97.92. The average price that ZBH shares were previous bought at was USD 107.997. The current market price is -9.3% lower than average price they were purchased at. The value of the holding in ZBH has increased by USD 91,244 compared to the previous valuation of Zimmer Biomet Holdings Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 222.23 | USD 0 | The current share valuation price of STE based on adjusted close was USD 222.23. The average price that STE shares were previous bought at was USD 221.717. The current market price is 0.2% higher than average price they were purchased at. The value of the holding in STE has increased by USD 103,143 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| COO - The Cooper Companies, Inc. Common Stock | HOLD | 0 @ USD 79.51 | USD 0 | The current share valuation price of COO based on adjusted close was USD 79.51. The average price that COO shares were previous bought at was USD 89.8782. The current market price is -11.5% lower than average price they were purchased at. The value of the holding in COO has increased by USD 122,082 compared to the previous valuation of The Cooper Companies, Inc. Common Stock however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| LH - Laboratory Corporation of America Holdings | HOLD | 0 @ USD 217.12 | USD 0 | The current share valuation price of LH based on adjusted close was USD 217.12. The average price that LH shares were previous bought at was USD 241.657. The current market price is -10.2% lower than average price they were purchased at. The value of the holding in LH has fallen by USD 134,622 compared to the previous valuation of Laboratory Corporation of America Holdings |
| PODD - Insulet Corporation | HOLD | 0 @ USD 246.8 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 246.8. The average price that PODD shares were previous bought at was USD 269.561. The current market price is -8.4% lower than average price they were purchased at. The value of the holding in PODD has fallen by USD 128,672 compared to the previous valuation of Insulet Corporation |
| RMD - ResMed Inc | HOLD | 0 @ USD 212.91 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 212.91. The average price that RMD shares were previous bought at was USD 235.04. The current market price is -9.4% lower than average price they were purchased at. The value of the holding in RMD has increased by USD 98,612 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| HOLX - Hologic Inc | HOLD | 0 @ USD 57.56 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 57.56. The average price that HOLX shares were previous bought at was USD 67.8373. The current market price is -15.1% lower than average price they were purchased at. The value of the holding in HOLX has increased by USD 112,328 compared to the previous valuation of Hologic Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| DGX - Quest Diagnostics Incorporated | HOLD | 0 @ USD 163.8 | USD 0 | The current share valuation price of DGX based on adjusted close was USD 163.8. The average price that DGX shares were previous bought at was USD 165.734. The current market price is -1.2% lower than average price they were purchased at. The value of the holding in DGX has fallen by USD 35,397 compared to the previous valuation of Quest Diagnostics Incorporated |
| BAX - Baxter International Inc | HOLD | 0 @ USD 28.89 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 28.89. The average price that BAX shares were previous bought at was USD 33.5164. The current market price is -13.8% lower than average price they were purchased at. The value of the holding in BAX has increased by USD 256,545 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| ALGN - Align Technology Inc | HOLD | 0 @ USD 171.41 | USD 0 | The current share valuation price of ALGN based on adjusted close was USD 171.41. The average price that ALGN shares were previous bought at was USD 190.424. The current market price is -10.0% lower than average price they were purchased at. The value of the holding in ALGN has increased by USD 142,263 compared to the previous valuation of Align Technology Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| VTRS - Viatris Inc | HOLD | 0 @ USD 7.56 | USD 0 | The current share valuation price of VTRS based on adjusted close was USD 7.56. The average price that VTRS shares were previous bought at was USD 10.5684. The current market price is -28.5% lower than average price they were purchased at. The value of the holding in VTRS has increased by USD 97,025 compared to the previous valuation of Viatris Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| RVTY - Revvity Inc. | HOLD | 0 @ USD 91.82 | USD 0 | The current share valuation price of RVTY based on adjusted close was USD 91.82. The average price that RVTY shares were previous bought at was USD 113.763. The current market price is -19.3% lower than average price they were purchased at. The value of the holding in RVTY has fallen by USD 112,089 compared to the previous valuation of Revvity Inc. |
| MRNA - Moderna Inc | HOLD | 0 @ USD 24.715 | USD 0 | The current share valuation price of MRNA based on adjusted close was USD 24.715. The average price that MRNA shares were previous bought at was USD 36.4077. The current market price is -32.1% lower than average price they were purchased at. The value of the holding in MRNA has fallen by USD 74,920 compared to the previous valuation of Moderna Inc |
| INCY - Incyte Corporation | HOLD | 0 @ USD 58.21 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 58.21. The average price that INCY shares were previous bought at was USD 69.7854. The current market price is -16.6% lower than average price they were purchased at. The value of the holding in INCY has increased by USD 36,766 compared to the previous valuation of Incyte Corporation however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| UHS - Universal Health Services Inc | HOLD | 0 @ USD 174.8 | USD 0 | The current share valuation price of UHS based on adjusted close was USD 174.8. The average price that UHS shares were previous bought at was USD 190.165. The current market price is -8.1% lower than average price they were purchased at. The value of the holding in UHS has increased by USD 31,125 compared to the previous valuation of Universal Health Services Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| TECH - Bio-Techne Corp | HOLD | 0 @ USD 48.1 | USD 0 | The current share valuation price of TECH based on adjusted close was USD 48.1. The average price that TECH shares were previous bought at was USD 67.0223. The current market price is -28.2% lower than average price they were purchased at. The value of the holding in TECH has fallen by USD 139,725 compared to the previous valuation of Bio-Techne Corp |
| CRL - Creightons Plc | HOLD | 0 @ USD 106.05 | USD 0 | The current share valuation price of CRL based on adjusted close was USD 106.05. The average price that CRL shares were previous bought at was USD 171.177. The current market price is -38.0% lower than average price they were purchased at. The value of the holding in CRL has increased by USD 44,532 compared to the previous valuation of Creightons Plc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| SOLV - Solventum Corp. | HOLD | 0 @ USD 66.26 | USD 0 | The current share valuation price of SOLV based on adjusted close was USD 66.26. The average price that SOLV shares were previous bought at was USD 74.7865. The current market price is -11.4% lower than average price they were purchased at. The value of the holding in SOLV has increased by USD 37,678 compared to the previous valuation of Solventum Corp. however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| HSIC - Henry Schein Inc | HOLD | 0 @ USD 64.73 | USD 0 | The current share valuation price of HSIC based on adjusted close was USD 64.73. The average price that HSIC shares were previous bought at was USD 73.4903. The current market price is -11.9% lower than average price they were purchased at. The value of the holding in HSIC has increased by USD 85,518 compared to the previous valuation of Henry Schein Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| DVA - DaVita HealthCare Partners Inc | HOLD | 0 @ USD 140.03 | USD 0 | The current share valuation price of DVA based on adjusted close was USD 140.03. The average price that DVA shares were previous bought at was USD 156.212. The current market price is -10.4% lower than average price they were purchased at. The value of the holding in DVA has fallen by USD 31,630 compared to the previous valuation of DaVita HealthCare Partners Inc |
| GILD - Guild Esports Plc | HOLD | 0 @ USD 104.54 | USD 0 | The current share valuation price of GILD based on adjusted close was USD 104.54. The average price that GILD shares were previous bought at was USD 102.556. The current market price is 1.9% higher than average price they were purchased at. The value of the holding in GILD has fallen by USD 200,074 compared to the previous valuation of Guild Esports Plc |
| UNH - UnitedHealth Group Incorporated | HOLD | 0 @ USD 454.11 | USD 0 | The current share valuation price of UNH based on adjusted close was USD 454.11. The average price that UNH shares were previous bought at was USD 535.348. The current market price is -15.2% lower than average price they were purchased at. The value of the holding in UNH has fallen by USD 56,895,370 compared to the previous valuation of UnitedHealth Group Incorporated |
| JNJ - Johnson & Johnson | HOLD | 0 @ USD 157.47 | USD 0 | The current share valuation price of JNJ based on adjusted close was USD 157.47. The average price that JNJ shares were previous bought at was USD 157.739. The current market price is -0.2% lower than average price they were purchased at. The value of the holding in JNJ has increased by USD 4,047,186 compared to the previous valuation of Johnson & Johnson however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| ABBV - AbbVie Inc | HOLD | 0 @ USD 172.99 | USD 0 | The current share valuation price of ABBV based on adjusted close was USD 172.99. The average price that ABBV shares were previous bought at was USD 193.27. The current market price is -10.5% lower than average price they were purchased at. The value of the holding in ABBV has increased by USD 1,091,992 compared to the previous valuation of AbbVie Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| MRK - Marks Electrical Group PLC | HOLD | 0 @ USD 78 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 78. The average price that MRK shares were previous bought at was USD 93.1573. The current market price is -16.3% lower than average price they were purchased at. The value of the holding in MRK has increased by USD 1,839,464 compared to the previous valuation of Marks Electrical Group PLC however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| MRK - Merck & Company Inc | HOLD | 0 @ USD 78 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 78. The average price that MRK shares were previous bought at was USD 93.1573. The current market price is -16.3% lower than average price they were purchased at. The value of the holding in MRK has increased by USD 1,839,464 compared to the previous valuation of Merck & Company Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| TMO - Time Out Group plc | HOLD | 0 @ USD 427.5 | USD 0 | The current share valuation price of TMO based on adjusted close was USD 427.5. The average price that TMO shares were previous bought at was USD 532.898. The current market price is -19.8% lower than average price they were purchased at. The value of the holding in TMO has fallen by USD 1,677,894 compared to the previous valuation of Time Out Group plc |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 130.98 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 130.98. The average price that ABT shares were previous bought at was USD 126.267. The current market price is 3.7% higher than average price they were purchased at. The value of the holding in ABT has increased by USD 1,048,295 compared to the previous valuation of Abbott Laboratories however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 482.74 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 482.74. The average price that ISRG shares were previous bought at was USD 546.225. The current market price is -11.6% lower than average price they were purchased at. The value of the holding in ISRG has increased by USD 235,775 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| AMGN - Amgen Inc | HOLD | 0 @ USD 277.29 | USD 0 | The current share valuation price of AMGN based on adjusted close was USD 277.29. The average price that AMGN shares were previous bought at was USD 304.248. The current market price is -8.9% lower than average price they were purchased at. The value of the holding in AMGN has fallen by USD 1,357,097 compared to the previous valuation of Amgen Inc |
| DHR - Danaher Corporation | HOLD | 0 @ USD 186.83 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 186.83. The average price that DHR shares were previous bought at was USD 219.847. The current market price is -15.0% lower than average price they were purchased at. The value of the holding in DHR has fallen by USD 1,158,088 compared to the previous valuation of Danaher Corporation |
| DHR - Danaher Corporation | HOLD | 0 @ USD 186.83 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 186.83. The average price that DHR shares were previous bought at was USD 219.847. The current market price is -15.0% lower than average price they were purchased at. The value of the holding in DHR has fallen by USD 1,158,088 compared to the previous valuation of Danaher Corporation |
| PFE - Pfizer Inc | HOLD | 0 @ USD 22.14 | USD 0 | The current share valuation price of PFE based on adjusted close was USD 22.14. The average price that PFE shares were previous bought at was USD 26.0678. The current market price is -15.1% lower than average price they were purchased at. The value of the holding in PFE has increased by USD 267,584 compared to the previous valuation of Pfizer Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 95.12 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 95.12. The average price that BSX shares were previous bought at was USD 98.4985. The current market price is -3.4% lower than average price they were purchased at. The value of the holding in BSX has fallen by USD 90,468 compared to the previous valuation of Boston Scientific Corporation |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 95.12 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 95.12. The average price that BSX shares were previous bought at was USD 98.4985. The current market price is -3.4% lower than average price they were purchased at. The value of the holding in BSX has fallen by USD 90,468 compared to the previous valuation of MULSTRXSSXIMETFP |
| SYK - Stryker Corporation | HOLD | 0 @ USD 346.5 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 346.5. The average price that SYK shares were previous bought at was USD 380.929. The current market price is -9.0% lower than average price they were purchased at. The value of the holding in SYK has fallen by USD 27,568 compared to the previous valuation of Stryker Corporation |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ USD 489.1 | USD 0 | The current share valuation price of VRTX based on adjusted close was USD 489.1. The average price that VRTX shares were previous bought at was USD 477.045. The current market price is 2.5% higher than average price they were purchased at. The value of the holding in VRTX has increased by USD 388,837 compared to the previous valuation of Vertex Pharmaceuticals Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| BMY - Bloomsbury Publishing Plc | HOLD | 0 @ USD 49.23 | USD 0 | The current share valuation price of BMY based on adjusted close was USD 49.23. The average price that BMY shares were previous bought at was USD 58.1196. The current market price is -15.3% lower than average price they were purchased at. The value of the holding in BMY has fallen by USD 124,565 compared to the previous valuation of Bloomsbury Publishing Plc |
| LLY - Eli Lilly and Company | HOLD | 0 @ USD 839.96 | USD 0 | The current share valuation price of LLY based on adjusted close was USD 839.96. The average price that LLY shares were previous bought at was USD 838.12. The current market price is 0.2% higher than average price they were purchased at. The value of the holding in LLY has increased by USD 39,087,678 compared to the previous valuation of Eli Lilly and Company however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| MDT - Medtronic PLC | HOLD | 0 @ USD 82.6 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 82.6. The average price that MDT shares were previous bought at was USD 89.1446. The current market price is -7.3% lower than average price they were purchased at. The value of the holding in MDT has fallen by USD 60,547 compared to the previous valuation of Medtronic PLC |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 424.53 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 424.53. The average price that ELV shares were previous bought at was USD 409.68. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in ELV has fallen by USD 1,146,547 compared to the previous valuation of Elevance Health Inc |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 424.53 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 424.53. The average price that ELV shares were previous bought at was USD 409.68. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in ELV has fallen by USD 1,146,547 compared to the previous valuation of Elevance Health Inc |
| CI - Cigna Corp | HOLD | 0 @ USD 330.13 | USD 0 | The current share valuation price of CI based on adjusted close was USD 330.13. The average price that CI shares were previous bought at was USD 313.959. The current market price is 5.2% higher than average price they were purchased at. The value of the holding in CI has increased by USD 89,213 compared to the previous valuation of Cigna Corp however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ USD 563.16 | USD 0 | The current share valuation price of REGN based on adjusted close was USD 563.16. The average price that REGN shares were previous bought at was USD 714.539. The current market price is -21.2% lower than average price they were purchased at. The value of the holding in REGN has increased by USD 691,432 compared to the previous valuation of Regeneron Pharmaceuticals Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| ZTS - Zoetis Inc | HOLD | 0 @ USD 148.67 | USD 0 | The current share valuation price of ZTS based on adjusted close was USD 148.67. The average price that ZTS shares were previous bought at was USD 168.289. The current market price is -11.7% lower than average price they were purchased at. The value of the holding in ZTS has increased by USD 403,851 compared to the previous valuation of Zoetis Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| MCK - McKesson Corporation | HOLD | 0 @ USD 697.08 | USD 0 | The current share valuation price of MCK based on adjusted close was USD 697.08. The average price that MCK shares were previous bought at was USD 612.44. The current market price is 13.8% higher than average price they were purchased at. The value of the holding in MCK has increased by USD 140,848 compared to the previous valuation of McKesson Corporation however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| CVS - CVS Health Corp | HOLD | 0 @ USD 67.29 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 67.29. The average price that CVS shares were previous bought at was USD 62.1919. The current market price is 8.2% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 750,099 compared to the previous valuation of CVS Health Corp |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 198.71 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 198.71. The average price that BDX shares were previous bought at was USD 231.159. The current market price is -14.0% lower than average price they were purchased at. The value of the holding in BDX has fallen by USD 229,764 compared to the previous valuation of Becton Dickinson and Company |
| HCA - HCA Holdings Inc | HOLD | 0 @ USD 335.01 | USD 0 | The current share valuation price of HCA based on adjusted close was USD 335.01. The average price that HCA shares were previous bought at was USD 336.277. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in HCA has increased by USD 338,596 compared to the previous valuation of HCA Holdings Inc however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| COR - Cencora Inc. | HOLD | 0 @ USD 286.74 | USD 0 | The current share valuation price of COR based on adjusted close was USD 286.74. The average price that COR shares were previous bought at was USD 251.231. The current market price is 14.1% higher than average price they were purchased at. The value of the holding in COR has increased by USD 187,314 compared to the previous valuation of Cencora Inc. however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 71.53 | USD 0 | The current share valuation price of EW based on adjusted close was USD 71.53. The average price that EW shares were previous bought at was USD 71.0156. The current market price is 0.7% higher than average price they were purchased at. The value of the holding in EW has increased by USD 91,978 compared to the previous valuation of Edwards Lifesciences Corp however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| A - Agilent Technologies Inc | HOLD | 0 @ USD 102.48 | USD 0 | The current share valuation price of A based on adjusted close was USD 102.48. The average price that A shares were previous bought at was USD 131.964. The current market price is -22.3% lower than average price they were purchased at. The value of the holding in A has fallen by USD 29,570 compared to the previous valuation of Agilent Technologies Inc |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 62.37 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 62.37. The average price that GEHC shares were previous bought at was USD 86.443. The current market price is -27.8% lower than average price they were purchased at. The value of the holding in GEHC has increased by USD 191,256 compared to the previous valuation of GE HealthCare Technologies Inc. however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| IQV - IQVIA Holdings Inc | HOLD | 0 @ USD 143.91 | USD 0 | The current share valuation price of IQV based on adjusted close was USD 143.91. The average price that IQV shares were previous bought at was USD 196.411. The current market price is -26.7% lower than average price they were purchased at. The value of the holding in IQV has fallen by USD 357,883 compared to the previous valuation of IQVIA Holdings Inc |